Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 23.02 | (629.16) | (472.26)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 173.09 | (595.41) | (432.22)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 419.41 | (407.79) | (277.67)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
Amgen picks up new heart drug | 28-May-2009 | Chicago Tribune |
Amgen pays $50 million for rights to heart drug | 27-May-2009 | LA Times |
A Tough Quarter for Some Drug Makers | 26-Jan-2007 | New York Times |
Currency | US Dollars |
Share Price | $ 38.67 |
Change Today | $ -0.05 |
% Change | -0.13 % |
52 Week High | $58.62 |
52 Week Low | $29.84 |
Volume | 1,214,446 |
Shares Issued | 55.37m |
Market Cap | $2,141.28m |
RiskGrade | 332 |
Strong Buy | 4 |
Buy | 12 |
Neutral | 5 |
Sell | 0 |
Strong Sell | 0 |
Total | 21 |
Time | Volume / Share Price |
16:00 | 227,373 @ $38.67 |
15:59 | 134 @ $38.66 |
15:59 | 100 @ $38.66 |
15:59 | 397 @ $38.66 |
15:59 | 112 @ $38.67 |
You are here: research